國華(00370.HK)擬7000萬港元收購建築承包公司
格隆匯12月18日丨國華(00370.HK)公佈,於2019年12月18日,公司全資附屬尚新擬以7000萬港元向楊雪及趙國琳收購Total Fame Holdings Limited全部已發行股本。根據協議,賣方承諾2019年溢利將不少於人民幣900萬元。
目標公司由楊雪及趙國琳分別擁有80%及20%權益。其為一間投資控股公司。全資持有江威陝西100%股權。江威陝西主要於中國從事建築項目承包業務。
鑑於中國建築行業的正面前景,董事認為,交易事項為集團提供進軍中國建築行業的機會,且預期集團將自多元化發展其收益來源中受益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.